Prevention of Peritoneal Carcinomatosis from Human Gastric Cancer Cells by Adjuvant-Type Intraperitoneal Immunotherapy in a SCID Mouse Model

scientific article published on 01 November 2003

Prevention of Peritoneal Carcinomatosis from Human Gastric Cancer Cells by Adjuvant-Type Intraperitoneal Immunotherapy in a SCID Mouse Model is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1159/000073385
P8608Fatcat IDrelease_j2xnsyguyzhaji4pwafwsmex7i
P953full work available at URLhttps://www.karger.com/Article/Pdf/73385
P698PubMed publication ID14593230

P2093author name stringH. J. Schlitt
P. Piso
J. Klempnauer
H. Aselmann
R. von Wasielewski
M. H. Dahlke
P2860cites workNK cells, MHC class I molecules and the missing selfQ34592442
Peritoneal cytology in the surgical evaluation of gastric carcinomaQ36618135
Immunocytochemically detected free peritoneal tumour cells (FPTC) are a strong prognostic factor in gastric carcinomaQ36618164
Targeted chemotherapy in mice with peritoneally disseminated gastric cancer using monoclonal antibody-drug conjugateQ41065372
Indications for early postoperative intraperitoneal chemotherapy of advanced gastric cancer: results of a prospective randomized trialQ43747422
Successful intraperitoneal hyperthermic chemoperfusion for the prevention of postoperative peritoneal recurrence in patients with advanced gastric carcinoma.Q51468726
Intraoperative lavage for cytological examination in 1,297 patients with gastric carcinomaQ73097148
Enhanced antitumor activity of a combination treatment with a mouse/human chimeric anti-MK-1 antibody and lymphokine-activated killer cells in vitro and in a severe combined immunodeficient mouse xenograft modelQ78080716
P433issue6
P407language of work or nameEnglishQ1860
P921main subjectsurgeryQ40821
immunologic adjuvantQ967453
immunotherapyQ1427096
peritoneal carcinomatosisQ2071182
P304page(s)470-476
P577publication date2003-11-01
P1433published inEuropean Surgical ResearchQ15755712
P1476titlePrevention of peritoneal carcinomatosis from human gastric cancer cells by adjuvant-type intraperitoneal immunotherapy in a SCID mouse model
Prevention of Peritoneal Carcinomatosis from Human Gastric Cancer Cells by Adjuvant-Type Intraperitoneal Immunotherapy in a SCID Mouse Model
P478volume35

Reverse relations

cites work (P2860)
Q40343216CDX2 does not suppress tumorigenicity in the human gastric cancer cell line MKN45.
Q34992944Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival of gastric cancer with peritoneal carcinomatosis: evidence from an experimental study

Search more.